1,25-dihydroxycholecalciferol

Calcitriol 1,25-dihydroxyvitamin D3

Therapeutic Indications

1,25-dihydroxycholecalciferol is indicated for:

at least one of
Rickets, active

Hypoparathyroidism

Postprocedural hypoparathyroidism

Osteoporosis with pathological fracture

Osteoporosis without pathological fracture

Osteoporosis in endocrine disorders

Vitamin D deficiency, unspecified

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral

at least one of
Osteopathy in other diseases classified elsewhere

Renal osteodystrophy

Osteochondrodysplasia, unspecified

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral

at least one of
Rickets, active

Hypoparathyroidism

Postprocedural hypoparathyroidism

Osteoporosis with pathological fracture

Osteoporosis without pathological fracture

Osteoporosis in endocrine disorders

Vitamin D deficiency, unspecified

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral

at least one of
Osteopathy in other diseases classified elsewhere

Renal osteodystrophy

Osteochondrodysplasia, unspecified

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral

Contraindications

Active ingredient 1,25-dihydroxycholecalciferol is contraindicated in the following cases:

No gender/age discrimination

at least one of
Hypervitaminosis D

Raised serum calcium level

Unspecified adverse effect of drug or medicament

Renal failure

Vitamin D3

Vitamin D2